Visible Alpha

Supercharge your analysis with ready-to-use templates designed to fit seamlessly into your existing workflow. From growth trends to multi-company comparisons and in-depth valuation models, our Excel add-ins offer everything you need to make smarter, faster decisions. Learn more: https://okt.to/0HhTRi

Attention IROs! 𝗖𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀 𝗼𝗻𝗹𝘆 𝘁𝗲𝗹𝗹𝘀 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝘀𝘁𝗼𝗿𝘆. While the consensus forecast gives a quick snapshot, 𝘁𝗵𝗲 𝗿𝗲𝗮𝗹 𝘃𝗮𝗹𝘂𝗲 𝗹𝗶𝗲𝘀 𝗶𝗻 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝘁 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 𝗮𝗻𝗱 𝘄𝗵𝘆 𝘁𝗵𝗲𝘆 𝗱𝗶𝗳𝗳𝗲𝗿. Visible Alpha provides granular insights beyond headline consensus numbers – allowing you to uncover the drivers behind each forecast. Take the example below: Analysts vary significantly in their revenue expectations for FY 2024, from impacts of supplier cost pressures to boosts from secondary product sales. These variations tell us more than just the average – they highlight key investment questions for IR teams to anticipate and address. 𝗪𝗶𝘁𝗵 𝗩𝗶𝘀𝗶𝗯𝗹𝗲 𝗔𝗹𝗽𝗵𝗮, 𝘆𝗼𝘂 𝗴𝗮𝗶𝗻 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗿𝗮𝗻𝗴𝗲 𝗼𝗳 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 "𝘄𝗵𝘆" 𝗯𝗲𝗵𝗶𝗻𝗱 𝘁𝗵𝗲𝗺. Request a demo today: https://okt.to/gmOHIG

Earnings season puts portfolio managers and analysts to the test, demanding quick decisions based on real-time insights. Visible Alpha offers several powerful features designed to help you uncover key market signals, track critical trends, and act with precision. Learn more at: https://okt.to/Yo2lNb

Check out this episode of IR in Focus featuring our Head of TMT Research, Melissa Otto. She dives into the changing dynamics of broker relationships, effective investor communication strategies, and the importance of consistent messaging in investor relations.

𝗦𝗽𝗲𝗻𝗱 𝗹𝗲𝘀𝘀 𝘁𝗶𝗺𝗲 𝗼𝗻 𝗱𝗮𝘁𝗮 𝗽𝗿𝗲𝗽 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲 𝘁𝗶𝗺𝗲 𝗼𝗻 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀. Easily compare companies with standardized segment-level forecasts and consensus estimates available with Visible Alpha. Take smartphones as an example: Analysts from Bank of America, Goldman Sachs, and Jefferies report iPhone units in different ways—whether it’s “Total iPhone Units,” “iPhone Sell-in Units,” or “iPhone Revenue Units.” Similarly, Samsung and Google report shipments with unique labels. Without standardization, aligning these data points can feel like an uphill battle. 𝗢𝘂𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝘀𝗲𝗮𝗺𝗹𝗲𝘀𝘀𝗹𝘆 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝘀 𝘁𝗵𝗲𝘀𝗲 𝘃𝗮𝗿𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻𝘁𝗼 𝗼𝗻𝗲 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗲𝗱 𝗱𝗮𝘁𝗮𝘀𝗲𝘁—like “Units - Products, Smartphones” for a clean, consistent view across companies and products. This makes it easy to compare, analyze, and forecast across the industry with confidence. Request a demo to learn more: https://okt.to/R0IS7B

From deal sourcing to due diligence to portfolio management and financial modeling, Visible Alpha helps private equity teams streamline their everyday workflows. Ready to try out Visible Alpha for yourself? Schedule a demo today: https://okt.to/rWK237

The financial landscape is rapidly evolving—characterized by increasing market volatility, declining assets under management, and more sophisticated client demands. Our white paper, 𝗧𝗵𝗲 𝗥𝗮𝗰𝗲 𝘁𝗼 𝗦𝘁𝗮𝘆 𝗔𝗵𝗲𝗮𝗱: 𝗛𝗼𝘄 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗔𝘀𝘀𝗲𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿𝘀 𝗔𝗿𝗲 𝗠𝗼𝗱𝗲𝗿𝗻𝗶𝘇𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗣𝗿𝗼𝗰𝗲𝘀𝘀, delves into practical solutions to combat these challenges, including: ♟️𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝘁𝗼 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗲 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗦𝗵𝗶𝗳𝘁𝘀: Learn effective methods to handle rising inflation and interest rates while maintaining robust operations. 🖥️𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗪𝗶𝘁𝗵 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Discover how integrating automation and advanced data models can transform your investment process, enhancing accuracy, speed, and scalability. 📈𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝗙𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: Learn how you can utilize Visible Alpha’s platform to access sell-side models from 200+ brokers covering over 7,000 companies in consensus. Our platform helps streamline research processes, offering tools for valuation opportunities, idea generation, modeling, forecasting, and benchmarking. Download the white paper today: https://okt.to/8Za1Rn

The pharmaceutical industry is constantly evolving, between the rising cost of drug development and increasingly complex drug launches, making it more challenging than ever to achieve ROI. In our eBook, 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀, we dive into these issues by tackling two essential questions: 🧭How do financial analysts navigate biopharma regulations, clinical trial approval processes, and dense competitive landscapes? 📊How can tools like Visible Alpha BioPharma be leveraged to access detailed drug metadata and financial insights to enhance strategic decision-making in the biotech and pharmaceutical industries? Want to know more? Download the eBook today: https://okt.to/Je7Yr5

You still have time to register for our upcoming joint webinar with S&P Global Market Intelligence, 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗦𝘁𝗼𝗿𝗺: 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗻𝗴 𝗔𝘀𝘀𝗲𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗩𝗼𝗹𝗮𝘁𝗶𝗹𝗲 𝗠𝗮𝗿𝗸𝗲𝘁𝘀, taking place tomorrow (Oct. 10) at 11 AM ET. In this webinar, you'll learn about innovative strategies and advanced tools that asset managers can implement to enhance their investment research processes, foster resilience, and drive efficiency. Key topics we'll cover: 💽Shifting focus from legacy systems to building technology wealth. 📈Leveraging premium datasets for cleaner, differentiated insights. 🖥️Exploring integrated platforms to support modern data applications. Register for the webinar today: https://okt.to/ukpdK2

Visible Alpha partners with over 200 leading brokerage firms from around the world to provide some of the most granular consensus and broker estimates data in the market. By sourcing data directly from sell-side analysts' full working models, we are able to provide powerful insights on thousands of companies globally and across 170+ different industries. Want to learn more about the granularity of our data? Check out our latest stats: https://okt.to/Azc9W4